{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:42:53Z","timestamp":1791686573805,"version":"4.3.4"},"reference-count":72,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1080\/13543776.2024.2419827","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T02:45:27Z","timestamp":1729651527000},"page":"1231-1254","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Coumarin derivatives as therapeutic candidates: a review of their updated patents (2017\u2013present)"],"prefix":"10.1080","volume":"34","author":[{"given":"Kalfagianni","family":"Malamati \u2013 Konstantina","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadjipavlou-Litina","family":"Dimitra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules181215613"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01192011"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310954"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115788"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.3235"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.3487"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.3827"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.762248"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020689"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/10406638.2022.2050268"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570179420666230707142817"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2020.127404"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2018.1463530"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/np0340652"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2016.05.010"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.06.152"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9OB02090J"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2018.1465853"},{"key":"e_1_3_5_21_1","unstructured":"Liang C Tian D Jia M et al. inventors; Current assignee Shaanxi university of science and technology coumarin-gossypol derivatives with antitumor activities and a method of preparing the same. CN107382944B. 2017."},{"key":"e_1_3_5_22_1","unstructured":"Seon-Kwang K Kyungjin L Changmin K et al. inventors; Pharmaceutical composition for treating cancer with suppressed side effects in the immune system. KR101968398B1. 2017."},{"key":"e_1_3_5_23_1","unstructured":"Di Lucrezia R Bergbrede T Nussbaumer P et al. inventors; Current assignee Max Planck Gesellschaft zur Foerderung der Wissenschaften eV lead discovery center GmbH coumarin derivatives processes for their preparation and uses thereof for the treatment of cancer. US20200291011A1. 2018."},{"key":"e_1_3_5_24_1","unstructured":"Daoshan Y Wei W. Current assignee Qingdao University of science and technology a kind of synthetic method of thiocoumarin. CN108383817A. 2018."},{"key":"e_1_3_5_25_1","unstructured":"Peterson BR. Current assignee university of Kansas coumarin-linked taxanes for detection and circumvention of cellular efflux. US10399964B2. 2018."},{"key":"e_1_3_5_26_1","unstructured":"Di Lucrezia R Bergbrede T Nussbaumer P et al. inventors; Current assignee Max Planck Gesellschaft zur Foerderung der Wissenschaften eV lead discovery center GmbH 4-phenyl-coumarin derivatives processes for their preparation and uses thereof for the treatment of cancer. US10703735B2. 2019."},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20441"},{"key":"e_1_3_5_28_1","unstructured":"Tosun F Miski M. The use of terpenic coumarine derivative molecules in the treatment of cancer disease. WO2019209232A2 - EP3784230B1. 2019."},{"key":"e_1_3_5_29_1","unstructured":"Xian L Fengxu Z Fei L et al. inventors; Current assignee Kunming medical university C-4 substituted coumarin compounds and preparation method and application thereof. CN112409368B. 2020."},{"key":"e_1_3_5_30_1","unstructured":"Xuetao X Zhiqing L Wanling X et al. inventors; Current assignee new material technology Co ltd application of coumarin derivative in inhibiting tyrosinase activity. CN111202730B. 2020."},{"key":"e_1_3_5_31_1","unstructured":"Mohler JL Fiandalo MV Watt D et al. inventors; Current assignee health research inc university of Kentucky research foundation coumarin-modified androgens for the treatment of prostate cancer. US20220218722A1. 2020."},{"key":"e_1_3_5_32_1","unstructured":"Hall BM Decorte BL King PJ et al. inventors; Mek inhibitors and therapeutic uses thereof. WO2021142144A1 - AU2021206684B2 - MX2022008456A - IL294384A - KR20220125803A - BR112022013593A2. 2021."},{"key":"e_1_3_5_33_1","unstructured":"Junli Y Chunyan S. Current assignee Lanzhou institute of chemical physics LICP of CAS natural compound with anti-pancreatic cancer activity and separation method and application thereof. CN113999245B. 2021."},{"key":"e_1_3_5_34_1","unstructured":"Xiaoxi Z. Current assignee langjierui Suzhou biotechnology Co ltd 8- (pyridine amide) substituted coumarin compound and preparation method and application thereof. CN112939955B. 2021."},{"key":"e_1_3_5_35_1","unstructured":"Yan L Xiaoguang C Xiaoxi Z. 8-(picolinamide) substituted coumarin compound and preparation method therefor and use thereof. WO2022183963A1. 2021."},{"key":"e_1_3_5_36_1","unstructured":"Ying Z Siyu K Zongyun J et al. inventors; Current assignee Yunnan University YNU coumarin derivative-based fluorescent probe molecule for detecting azo reductase as well as preparation method and application thereof. CN113121488B. 2021."},{"key":"e_1_3_5_37_1","unstructured":"Ming J Jing J. Current assignee gangke penghe biology Suzhou Co ltd 8- (indoletriazole) substituted coumarin compound and preparation method and application thereof. CN113149971B. 2021."},{"key":"e_1_3_5_38_1","unstructured":"Yan L Xiaoguang C Xiaoxi Z. 8-(pyridine triazole) substituted coumarin-type compound and preparation method therefor and application thereof. Cn113149970b (2021)\/Wo2022183964a1. 2022."},{"key":"e_1_3_5_39_1","unstructured":"Soares LRB. Clarence Ray Hurt compounds compositions methods and uses for treating cancer and immunological disorders. WO2020014541A2. 2019."},{"key":"e_1_3_5_40_1","unstructured":"Shuyuan Z. Current assignee ruby inspection and testing Guangzhou Co Ltd Formononetin derivative and preparation method and application thereof. CN113845549B. 2021."},{"key":"e_1_3_5_41_1","article-title":"Current assignee academy of military medical sciences AMMS of PLA, coumarin-containing linker and antibody-conjugated drug containing the same","author":"Xinbo Z","year":"2021","unstructured":"Xinbo Z, Dian X, Shiyong F, et al. inventors; Current assignee academy of military medical sciences AMMS of PLA, coumarin-containing linker and antibody-conjugated drug containing the same. CN114605367B. 2021.","journal-title":"CN114605367B"},{"key":"e_1_3_5_42_1","unstructured":"Xiaoxi Z. Current assignee langjierui Suzhou biotechnology Co ltd 8- (benzothiazole amide) substituted coumarin compound and preparation method and application thereof. CN113149979B. 2021."},{"key":"e_1_3_5_43_1","unstructured":"Huazheng LL Yuji W. Current assignee capital medical university coumarin modified phenylboronic acid derivative and preparation method thereof curcumin dynamic covalent complex and preparation method and application thereof. CN115010733B. 2022."},{"key":"e_1_3_5_44_1","unstructured":"Hall BM Decorte BL King PJ et al. inventors; Mek immune oncology inhibitors and therapeutic uses thereof. WO2023133472A1. 2023."},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.2.0428"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.00220"},{"key":"e_1_3_5_47_1","unstructured":"Zheshan Q Lihua C Qingkun S et al. inventors; Current assignee Yanbian University a kind of furocoumarin compound and preparation method thereof and medical application. CN110229166A. 2019."},{"key":"e_1_3_5_48_1","unstructured":"Liqin H Feiyang S Bing H et al. inventors; Current assignee individual 7-hydroxy-3-acetyl coumarin oxime compound preparation method and medical application thereof. CN114920722B. 2021."},{"key":"e_1_3_5_49_1","unstructured":"Peiqing L Yong Z Zeyu L et al. inventors; Current assignee sun yat sen university 3-aryl coumarin derivative and preparation method and application thereof. CN113121485B. 2021."},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39162"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102862"},{"key":"e_1_3_5_52_1","unstructured":"Jie S Bing W Xiaojing W et al. inventors; Current assignee institute of materia medica Shandong academy of medical sciences (Shandong anti-aging research center Shandong new technology pharmaceutical research institute) a kind of application of 3- aryl-coumarins class compound. CN108653276A. 2018."},{"key":"e_1_3_5_53_1","unstructured":"Chae-Jo L Gyu-Yang L Byeong-Ho L et al. Inventors; coumarin-3-carboxamide derivatives preparation method therof and pharmaceutical composition for use in preventing or treating urotensin-II receptor activity related diseases containing the same as an active ingredient. KR102174395B1. 2018."},{"key":"e_1_3_5_54_1","unstructured":"Guangcheng W Zhiyun P Yongjun L et al. inventors; Current assignee Guizhou medical university coumarin-oxazole-ethylene type alpha-glucosidase inhibitor and preparation method and application thereof. CN108558851B. 2018."},{"key":"e_1_3_5_55_1","unstructured":"Zhaoguang Z Anping Y. Current assignee Foshan University application of 4-methyl-6 7-dimethoxycoumarin in preparing medicine for preventing and treating diabetic nephropathy. CN110934864A. 2019."},{"key":"e_1_3_5_56_1","doi-asserted-by":"crossref","unstructured":"Zhongmei Z Tao Z Chenxu Z. Current assignee institute of medicinal plant development of CAMS and PUMC monoterpene coumarin compound preparation method and application thereof. CN113461704B. 2021.","DOI":"10.1016\/j.focat.2021.10.033"},{"key":"e_1_3_5_57_1","unstructured":"Haiyan L Shaoxiong H Ke C. Current assignee changxing synthetic resin (Changshu) Co. ltd a kind of preparation method of anti-aging moisture curing vinylite. CN107915847A. 2017."},{"key":"e_1_3_5_58_1","unstructured":"Beomju L Seulhae L Gwangwon H. A new coumarin compound isolated from Fraxinus rhynchophylla preparation method thereof and anti-wrinkle composition containing the same as an active ingredient. KR102283289B1. 2019."},{"key":"e_1_3_5_59_1","unstructured":"Xueyang D Fei Y. Current assignee hangzhou weike brand management Co ltd skin anti-aging composition and application and skin care product thereof. CN116421517B. 2023."},{"key":"e_1_3_5_60_1","unstructured":"Qianjin L Yue X. Application of wedelolactone in preparation of medicines for treating systemic lupus erythematosus. CN116672338B. 2023."},{"key":"e_1_3_5_61_1","unstructured":"Srigiridhar K Santosh K Babu VS et al. inventors; Current assignee council of scientific and industrial research CSIR antioxidant compound having anti atherosclerotic effect and preparation thereof. US9580452B2. 2017."},{"key":"e_1_3_5_62_1","unstructured":"Popova SA Chukicheva IY Kuchin AV. Coumarins with bicyclic monoterpene substitutes. RU2707103C1. 2019."},{"key":"e_1_3_5_63_1","unstructured":"Gaolei X Zhifei C Qingfu W et al. inventors; Current assignee china tobacco Henan industrial Co ltd (E) -4-methyl-7-hydroxy-8- (3- (ferrocenyl) acryloyl) coumarin and preparation method and application thereof. CN113512074B. 2021."},{"key":"e_1_3_5_64_1","unstructured":"Kulikova OI Stvolinsky SL Fedorova TN et al. inventors; 5 8-dimethoxy-6 7-methylenedioxycoumarin derivatives having antiradical activity. RU2814111C1. 2023."},{"key":"e_1_3_5_65_1","unstructured":"Trkovnik M Cacic M Rizvani J. Current assignee I-Nova Medicinska Istrazivanja coumarin derivative as anti-asthmatic agent pharmaceutical composition thereof its preparation and use. EP3606517A1. 2017."},{"key":"e_1_3_5_66_1","unstructured":"Li \u03a5 Junwei H Ronghua L. Current assignee Jiangxi university of traditional Chinese medicine ginseng coumarin compound and application thereof in medicine. CN111808155B. 2021."},{"key":"e_1_3_5_67_1","unstructured":"Zhuanxia P. Current assignee individual a kind of cumarin eye drops and preparation method. CN107441035A. 2017."},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2012.678835"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2014.972368"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2017.1360284"},{"issue":"6","key":"e_1_3_5_71_1","first-page":"236","article-title":"Coumarin: chemical and pharmacological profile","volume":"2","author":"Jain P","year":"2012","unstructured":"Jain P, Joshi H. Coumarin: chemical and pharmacological profile. J Appl Pharm Sci. 2012;2(6):236\u2013240.","journal-title":"J Appl Pharm Sci"},{"key":"e_1_3_5_72_1","first-page":"1211","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"Burke AS","year":"2005","unstructured":"Burke AS, FitzGerald GA. Analgesic-antipyretic and antiinflammatory agents; pharmacotherapy of gout. In: Brunton L, Lazo J Parker K, editors. Goodman & Gilman\u2019s the pharmacological basis of therapeutics. 11th ed. McGraw-Hill Education; 2005. p. 1211\u20131218."},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043382710"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-020-00248-y"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2024.2419827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:03:07Z","timestamp":1733227387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2024.2419827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1080\/13543776.2024.2419827"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2024.2419827","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}